Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
SPRO
#3193
Spero Therapeutics, Inc. Common Stock
2.1
7
-0.46%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.46%
Variazione Mensile
-8.05%
Variazione di 6 mesi
+10.15%
Variazione Annuale
+178.21%
Chiusura Precedente
2.1
8
Open
2.1
7
Bid
Ask
Low
2.1
7
High
2.1
7
Volume
8
Mercati
Mercato Azionario Statunitense
Salute
SPRO
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
54.52 M
55.9 M
55.91 M
56.28 M
56.34 M
—
Valuation ratios
Enterprise value
-3.24 M
4.69 M
-8.63 M
132 M
57.3 M
185.36 M
Price to earnings ratio
16.75
-0.81
-0.56
-2.96
-2.38
-6.71
Price to sales ratio
0.67
1.16
0.87
3.26
2.55
7.85
Price to cash flow ratio
4.04
-2.37
1.82
4.95
1.66
6.05
Price to book ratio
0.21
1.21
0.17
0.89
0.74
3.01
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.13
0.19
0.18
0.03
0.14
0.53
Return on equity %
0.26
0.45
0.41
0.05
0.28
1.19
Return on invested capital %
113.69
—
—
—
195.47
—
Gross margin %
100
100
100
100
100
400
Operating margin %
138.04
144.41
250.78
17.22
145.46
557.88
EBITDA margin %
—
—
—
—
—
—
Net margin %
126.96
138.85
236.06
11.98
135.65
522.53
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.68
2.19
2.56
3.97
3.83
12.56
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.09
0.12
0.06
0.2
0.09
0.48
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
—
Per share metrics
Operating cash flow per share
0.24
-0.43
-0.07
-0.32
-0.31
-1.13
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.41
0.98
0.88
0.56
0.86
3.28
Net current asset value per share
2.43
1.99
1.35
1.06
0.93
5.32
Tangible book value per share
1.21
0.85
0.61
0.59
0.47
2.52
Working capital per share
1.52
1.08
0.82
0.79
0.69
3.38
Book value per share
1.21
0.85
0.61
0.59
0.47
2.52
Notizie
Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO)
キューツァー氏、Spero Therapeutics COOが44,000ドル相当の株式を売却
Keutzer, Spero Therapeutics COO, sells $44k in shares
スペロ・セラピューティクスのCEOが20万7千ドル相当の株式を売却
Spero Therapeutics CEO sells $207k in stock
GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook
Spero Therapeutics announces board resignation and SEC investigation closure
GSK files NDA resubmission for Spero’s tebipenem HBr antibiotic
【決算速報】Spero Therapeutics Inc、売上高は予想を下回り、利益は予想を上回る結果に
Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates
スペロ・セラピューティクスのCEOラジャベル氏、9.5万ドル相当の株式を売却
Spero therapeutics CEO Rajavelu sells $95k in stock